Trial Profile
A Prospective Multicentre Pilot Study of the Effectiveness of an Intra-operative Intravitreal Sustained Release Dexamethasone Implant (Ozurdex) in Vitrectomy Surgery for Epiretinal Membranes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 28 Jan 2015 New trial record